Adult GlioblastomaPhase 1NCT04573140Papers
Autologous total tumor mRNA
RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Glioblastoma (GBM)
B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors
What the film says
Diffuse midline glioma grows in a child's brainstem, where no surgeon can cut. Radiation buys time; half of these children live under a year.
The idea: teach the child's own immune cells to find the tumor, and deliver them straight into the brain.
T cells from the child's blood are fitted with a receptor for B7-H3, a marker most of these tumors carry. Then, instead of a vein, they go through a small catheter into the fluid around the brain, dose after dose, over months.
In the first twenty-one children, repeated doses were tolerable, and three were alive more than three and a half years after diagnosis.
BrainChild-03, at Seattle Children's, now asks the same question in more tumors. Public record; not medical advice.
Sources behind this film
Vitanza NA. Nat Med, 2025
Brainstem tumor, no surgery; half of children with DIPG live under a year; T cells fitted with a receptor for B7-H3, a marker most of these tumors carry; Catheter into the fluid around the brain, repeated doses over months; Twenty-one children treated; tolerable; three alive at 44, 45, 52 months from diagnosis
T cells fitted with a receptor for B7-H3, a marker most of these tumors carry; Catheter into the fluid around the brain, repeated doses over months; Twenty-one children treated; tolerable; three alive at 44, 45, 52 months from diagnosis; Now asks the same question in more of these tumors
The drug
Autologous CD4+ and CD8+ T cells lentivirally transduced to express a B7H3 specific chimeric antigen receptor (CAR) and EGFRt given via indwelling central nervous system (CNS) catheter
Patients with supratentorial tumors will be assigned to Arm A, and will receive their treatment into the tumor cavity. Patients with either infratentorial or metastatic/leptomeningeal tumors will be assigned to Arm B, and will have their treatment delivered into the ventricular system. The first 3 patients enrolled onto the study must be at least 15 years of age and assigned to Arm A or Arm B.
The study
This is a Phase 1 study of central nervous system (CNS) locoregional adoptive therapy with autologous CD4+ and CD8+ T cells lentivirally transduced to express a B7H3-specific chimeric antigen receptor (CAR) and EGFRt. CAR T cells are delivered via an indwelling catheter into the tumor resection cavity or ventricular system in children and young adults with diffuse intrinsic pontine glioma (DIPG), diffuse midline glioma (DMG), and recurrent or refractory CNS tumors.
A child or young adult meeting all eligibility criteria, including having a CNS catheter placed into the tumor resection cavity or into their ventricular system, and meeting none of the exclusion criteria, will have their T cells collected. The T cells will then be bioengineered into a second-generation CAR T cell that targets B7H3-expressing tumor cells. Patients will be assigned to one of 3 treatment arms based on location or type of their tumor.
Eligibility
Inclusion criteria as written on the registry, trimmed. The full list, with exclusions, is on the live record.
For you, or someone you love
A complex diagnosis brings new questions every week, in a trial and out of one. Triangle keeps your whole medical file together, reads it with you in plain language, and helps you and your family decide what to ask next.
Then $9 a month. Cancel anytime.
Requested from your hospitals and clinics through the national networks. Add scans, pathology and anything on paper.
Reports explained as they come in, with lab values you can follow before treatment, during a trial and after.
Ask about your own file, and walk in with questions for your oncologist or the trial team.
Share one profile with the family helping you, and with your doctors.
Members also get a deeper analysis of their records and any sequencing data, including clinical trials that may fit, reviewed by a licensed physician before they receive it.
It turns into a project to manage: visits, scans, labs, side effects and paperwork. Triangle keeps it organized in one place for you or for whoever's helping.
Organize my trial7-day free trial, then $9 a month. Cancel anytime.
How these trials work: what Phase 1 actually is · common questions Not clinical evidence.